{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T16:55:14Z","timestamp":1648572914051},"reference-count":14,"publisher":"Elsevier BV","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["SSRN Journal"],"DOI":"10.2139\/ssrn.1365871","type":"journal-article","created":{"date-parts":[[2011,12,28]],"date-time":"2011-12-28T13:11:01Z","timestamp":1325077861000},"source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Pharmaceutical Policy Measures: A Structural-Break Approach"],"prefix":"10.2139","author":[{"given":"Pedro P.","family":"Barros","sequence":"first","affiliation":[]},{"given":"Luis M.R.C.","family":"Nunes","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"5","key":"ref1","first-page":"1","article-title":"Portugal: Health System Review","volume":"9","author":"P P Barros","year":"2007","journal-title":"Health Systems in Transition"},{"issue":"10","key":"ref2","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/hec.1317","article-title":"Pharmaceutical expenditure, total health-care expenditure and GDP","volume":"17","author":"J Clemente","year":"2008","journal-title":"Health Economics"},{"issue":"3","key":"ref3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/hec.931","article-title":"The impact of price regulation on the launch delay of new drugs -evidence from twenty-five markets in the 1990s","volume":"14","author":"P Danzon","year":"2005","journal-title":"Health Economics"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/00019053-200826010-00002","article-title":"The last decade of Italian pharmaceutical policy: instability or consolidation?","volume":"26","author":"G Fattore","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.econmod.2009.07.019","author":"C Fiorio","year":"2008","journal-title":"The demand for pharmaceuticals: evidence from Italy, mimeo"},{"key":"ref6","article-title":"Forecasting","author":"A C Harvey","year":"1989","journal-title":"Structural Time Series Models and the Kalman Filter"},{"issue":"4","key":"ref7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2307\/1391813","article-title":"Diagnostic Checking of Unobserved-Components Time Series Models","volume":"10","author":"A C Harvey","year":"1992","journal-title":"Journal of Business & Economic Statistics"},{"key":"ref8","volume":"8","author":"S J Koopman","year":"2007","journal-title":"Structural Time Series Analyser, Modeller and Predictor"},{"issue":"9","key":"ref9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2165\/00019053-200624090-00006","article-title":"Impacts of costcontainment strategies on pharmaceutical expenditures of the National Health Insurance in Taiwan","volume":"24","author":"Y.-C Lee","year":"1996","journal-title":"Pharmacoeconomics"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1377\/hlthaff.22.3.31","volume":"22","author":"A Maynard","year":"2004","journal-title":"Dilemmas in the regulation of the market for pharmaceuticals"},{"issue":"3","key":"ref11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1468-246x.2006.00245.x","article-title":"Pharmaceutical pricing in Europe: weighing up the options","volume":"59","author":"E Mossialos","year":"2006","journal-title":"International Social Security Review"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-2918(03)80082-6","author":"M Ong","year":"1990","journal-title":"A time-series analysis of increased copayments on the prescription of antidepressants, anxiolytics, and sedatives in Sweden from"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.869762","article-title":"The Determinants of Public Pharmaceutical Expenditures: Does Italian Health Federalism Impact on Them?","author":"A Sisto","year":"2005","journal-title":"Available at SSRN"},{"issue":"4","key":"ref14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s0167-6296(98)00042-3","article-title":"Cost-sharing and pharmaceutical expenditure in Russia","volume":"18","author":"A Street","year":"1999","journal-title":"Journal of Health Economics"}],"container-title":["SSRN Electronic Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T20:01:47Z","timestamp":1558123307000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ssrn.com\/abstract=1365871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":14,"URL":"https:\/\/doi.org\/10.2139\/ssrn.1365871","relation":{},"ISSN":["1556-5068"],"issn-type":[{"value":"1556-5068","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009]]},"published":{"date-parts":[[2009]]}}}